Amplia Therapeutics Ltd (ATX) - Net Assets

Latest as of September 2025: AU$42.93 Million AUD ≈ $30.37 Million USD

Based on the latest financial reports, Amplia Therapeutics Ltd (ATX) has net assets worth AU$42.93 Million AUD (≈ $30.37 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$44.54 Million ≈ $31.52 Million USD) and total liabilities (AU$1.61 Million ≈ $1.14 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ATX financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	AU$42.93 Million
% of Total Assets	96.38%
Annual Growth Rate	8.75%
5-Year Change	103.34%
10-Year Change	425.19%
Growth Volatility	99.71

Amplia Therapeutics Ltd - Net Assets Trend (2010–2025)

This chart illustrates how Amplia Therapeutics Ltd's net assets have evolved over time, based on quarterly financial data. Also explore ATX total asset value for the complete picture of this company's asset base.

Annual Net Assets for Amplia Therapeutics Ltd (2010–2025)

The table below shows the annual net assets of Amplia Therapeutics Ltd from 2010 to 2025. For live valuation and market cap data, see ATX market cap overview.

Year	Net Assets	Change
2025-03-31	AU$21.02 Million ≈ $14.88 Million	+84.13%
2024-03-31	AU$11.42 Million ≈ $8.08 Million	-27.89%
2023-03-31	AU$15.84 Million ≈ $11.20 Million	-27.52%
2022-03-31	AU$21.85 Million ≈ $15.46 Million	+111.29%
2021-03-31	AU$10.34 Million ≈ $7.32 Million	+20.15%
2020-03-31	AU$8.61 Million ≈ $6.09 Million	-0.68%
2019-03-31	AU$8.66 Million ≈ $6.13 Million	+266.48%
2018-03-31	AU$2.36 Million ≈ $1.67 Million	-64.33%
2017-03-31	AU$6.63 Million ≈ $4.69 Million	+65.59%
2016-03-31	AU$4.00 Million ≈ $2.83 Million	-17.73%
2015-03-31	AU$4.87 Million ≈ $3.44 Million	-50.21%
2014-03-31	AU$9.77 Million ≈ $6.91 Million	-13.02%
2013-03-31	AU$11.23 Million ≈ $7.95 Million	+251.66%
2012-03-31	AU$3.19 Million ≈ $2.26 Million	-47.41%
2011-03-31	AU$6.07 Million ≈ $4.30 Million	+1.61%
2010-03-31	AU$5.98 Million ≈ $4.23 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Amplia Therapeutics Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 5686647600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (March 2025)

Component	Amount	Percentage
Common Stock	AU$167.39 Million	796.15%
Other Comprehensive Income	AU$-826.19K	-3.93%
Total Equity	AU$21.02 Million	100.00%

Amplia Therapeutics Ltd Competitors by Market Cap

The table below lists competitors of Amplia Therapeutics Ltd ranked by their market capitalization.

Company	Market Cap
Akin Tekstil AS IS:ATEKS	$50.85 Million
Archer Materials Limited F:38A	$50.89 Million
Greenland Mines Ltd NASDAQ:GRML	$50.92 Million
DAEMO Engineering Co. Ltd KQ:317850	$50.94 Million
Cross Timbers Royalty Trust NYSE:CRT	$50.82 Million
Southport Acquisition Corp NYSE:PORT	$50.81 Million
Matsa Resources Ltd AU:MAT	$50.81 Million
Broadwind Energy Inc NASDAQ:BWEN	$50.81 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Amplia Therapeutics Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 11,418,309 to 21,024,950, a change of 9,606,641 (84.1%).
Net loss of 6,572,031 reduced equity.
Share repurchases of 1,330,243 reduced equity.
New share issuances of 17,280,909 increased equity.
Other comprehensive income increased equity by 270,346.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	AU$-6.57 Million	-31.26%
Share Repurchases	AU$1.33 Million	-6.33%
Share Issuances	AU$17.28 Million	+82.19%
Other Comprehensive Income	AU$270.35K	+1.29%
Other Changes	AU$-42.34K	-0.2%
Total Change	AU$-	84.13%

Book Value vs Market Value Analysis

This analysis compares Amplia Therapeutics Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 2.05x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has increased from 0.50x to 2.05x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2010-03-31	AU$0.28	AU$0.14	x
2011-03-31	AU$0.29	AU$0.14	x
2012-03-31	AU$0.15	AU$0.14	x
2013-03-31	AU$0.65	AU$0.14	x
2014-03-31	AU$0.75	AU$0.14	x
2015-03-31	AU$0.26	AU$0.14	x
2016-03-31	AU$0.19	AU$0.14	x
2017-03-31	AU$0.28	AU$0.14	x
2018-03-31	AU$0.09	AU$0.14	x
2019-03-31	AU$0.20	AU$0.14	x
2020-03-31	AU$0.16	AU$0.14	x
2021-03-31	AU$0.11	AU$0.14	x
2022-03-31	AU$0.15	AU$0.14	x
2023-03-31	AU$0.08	AU$0.14	x
2024-03-31	AU$0.06	AU$0.14	x
2025-03-31	AU$0.07	AU$0.14	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Amplia Therapeutics Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -31.26%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -173.69%
• Asset Turnover: 0.16x
• Equity Multiplier: 1.09x
Recent ROE (-31.26%) is above the historical average (-62.63%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2010	-67.99%	0.00%	0.00x	1.37x	AU$-4.66 Million
2011	-40.21%	0.00%	0.00x	1.29x	AU$-3.05 Million
2012	-101.84%	0.00%	0.00x	1.80x	AU$-3.57 Million
2013	-30.16%	0.00%	0.00x	1.02x	AU$-4.51 Million
2014	-46.00%	0.00%	0.00x	1.04x	AU$-5.47 Million
2015	-107.62%	-17278.70%	0.01x	1.09x	AU$-5.72 Million
2016	-123.48%	-218.40%	0.45x	1.26x	AU$-5.34 Million
2017	-106.75%	-393.54%	0.24x	1.14x	AU$-7.74 Million
2018	-181.77%	-740.59%	0.22x	1.12x	AU$-4.53 Million
2019	-21.58%	-3704.79%	0.01x	1.06x	AU$-2.74 Million
2020	-25.79%	-6484.57%	0.00x	1.06x	AU$-3.08 Million
2021	-22.06%	-148.75%	0.14x	1.05x	AU$-3.32 Million
2022	-16.68%	-183.74%	0.08x	1.12x	AU$-5.83 Million
2023	-39.42%	-524.80%	0.06x	1.18x	AU$-7.83 Million
2024	-39.44%	-101.14%	0.30x	1.30x	AU$-5.65 Million
2025	-31.26%	-173.69%	0.16x	1.09x	AU$-8.67 Million

Industry Comparison

This section compares Amplia Therapeutics Ltd's net assets metrics with peer companies in the Biotechnology industry.

Industry Context

Industry: Biotechnology
Average net assets among peers: $9,652,467
Average return on equity (ROE) among peers: -75.61%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Amplia Therapeutics Ltd (ATX)	AU$42.93 Million	-67.99%	0.04x	$50.82 Million
Adalta Ltd (1AD)	$3.70 Million	-162.25%	0.87x	$6.50 Million
Algorae Pharmaceuticals Ltd (1AI)	$-1.33 Million	0.00%	0.00x	$20.04 Million
ACRUX Ltd (ACR)	$12.85 Million	-73.71%	0.44x	$3.20 Million
Actinogen Medical Ltd (ACW)	$21.74 Million	-43.69%	0.07x	$105.70 Million
Argenica Therapeutics Ltd (AGN)	$13.95 Million	-39.28%	0.17x	$15.45 Million
Arovella Therapeutics Ltd (ALA)	$11.03 Million	-40.87%	0.23x	$58.08 Million
Anatara Lifesciences Ltd (ANR)	$924.54K	-218.83%	0.54x	$1.57 Million
Alterity Therapeutics Ltd (ATH)	$20.73 Million	-6.40%	0.01x	$76.95 Million
Avecho Biotechnology Ltd (AVE)	$3.27 Million	-95.48%	0.53x	$28.59 Million

About Amplia Therapeutics Ltd

AU:ATX Australia Biotechnology

Market Cap

$50.82 Million

AU$71.83 Million AUD

Market Cap Rank

#21825 Global

#789 in Australia

Share Price

AU$0.14

Change (1 day)

-6.67%

52-Week Range

AU$0.05 - AU$0.36

All Time High

AU$16.20